acc 2018: anti-platelet therapy in pci - adapt
Published 6 years ago • 23 plays • Length 5:51Download video MP4
Download video MP3
Similar videos
-
4:30
acc 2018: statins evaluation in coronary procedures & revascularization trial
-
26:45
platelet reactivity testing round table session 2: treatment options for high-risk pci patients
-
5:17
de-escalation of antiplatelet treatment in acs patients undergoing pci at esc 2017
-
36:46
journal club - dual antiplatelet therapy after pci in patients at high bleeding risk (master dapt)
-
42:40
balancing the efficiency and safety of antiplatelet agents in acute coronary syndrome (acs)
-
6:45
dual anti-platelet therapy: how long after pci, cabg, acs?
-
16:30
dual antiplatelet therapy after pci in 2024
-
9:28
acc 22: ffr vs. ivus-guided pci in intermediate coronary artery stenosis: the flavour trial | dr koo
-
52:11
master dapt trial: dual antiplatelet therapy after coronary stenting - aict-asiapcr 2021
-
11:46
acc 21: findings from the host-exam trial
-
46:47
antiplatelet therapy in high bleeding risk patients following pci, november 6, 2020
-
1:08:13
optimizing the benefit of antiplatelet therapy in high risk post-pci patients
-
12:01
apt: continuing dual antiplatelet therapy (dapt) post-pci
-
6:49
esc 24: epic-cad: edoxaban vs dual antiplatelet therapy in af & cad
-
0:40
ccd guideline - antiplatelet therapy
-
47:23
genotype directed antiplatelet therapy, is the time right?
-
2:17
stopdapt-2 act: 1-month dapt followed by clopidogrel monotherapy in acs | dr hirotoshi watanabe
-
2:48
stopdapt-2 | acc.19